Quick Answer
PACIFIC BIOSCIENCES OF CALIFORNIA, INC. reported Net Income Loss of -$546.38 million for the year ending 2025.
- PACIFIC BIOSCIENCES OF CALIFORNIA, INC. showed a decrease of -76.3% in Net Income Loss from 2024 to 2025.
- This data is from PACIFIC BIOSCIENCES OF CALIFORNIA, INC.'s annual report (Form 10-K), filed with the SEC on February 25, 2026.
- XBRL data for this metric is available from 2009 to 2025 (17 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q3 2013: -$20.49 million | Q4 2013: -$17.23 million | Q1 2014: -$18.89 million | Q2 2014: -$19.14 million | Q3 2014: -$9.16 million | Q4 2014: -$18.98 million | Q1 2015: -$20.17 million | Q2 2015: -$11.94 million | Q3 2015: $1.82 million | Q4 2015: -$1.41 million | Q1 2016: -$19.35 million | Q2 2016: -$18.50 million | Q3 2016: -$17.49 million | Q4 2016: -$19.03 million | Q1 2017: -$23.87 million | Q2 2017: -$25.54 million | Q3 2017: -$22.02 million | Q4 2017: -$20.76 million | Q1 2018: -$24.18 million | Q2 2018: -$22.54 million | Q3 2018: -$25.04 million | Q4 2018: -$30.80 million | Q1 2019: -$30.32 million | Q2 2019: -$24.60 million | Q3 2019: -$29.12 million | Q4 2019: -$91.0 thousand | Q1 2020: $1.26 million | Q2 2020: -$23.09 million | Q3 2020: -$23.71 million | Q1 2021: -$87.44 million | Q2 2021: -$41.00 million | Q3 2021: $16.54 million | Q1 2022: -$81.50 million | Q2 2022: -$71.39 million | Q3 2022: -$76.97 million | Q1 2023: -$88.02 million | Q2 2023: -$69.83 million | Q3 2023: -$66.87 million | Q1 2024: -$78.18 million | Q2 2024: -$173.32 million | Q3 2024: -$60.73 million | Q1 2025: -$426.08 million | Q2 2025: -$41.93 million | Q3 2025: -$38.00 million.
- Over the full 17 years of available data (2009 to 2025), PACIFIC BIOSCIENCES OF CALIFORNIA, INC.'s Net Income Loss has declined by 523.0%.
- Historical annual values: Fiscal year 2025: -$546.38 million | Fiscal year 2024: -$309.85 million | Fiscal year 2023: -$306.74 million | Fiscal year 2022: -$314.25 million | Fiscal year 2021: -$181.22 million | Fiscal year 2020: $29.40 million | Fiscal year 2019: -$84.13 million | Fiscal year 2018: -$102.56 million | Fiscal year 2017: -$92.19 million | Fiscal year 2016: -$74.38 million | Fiscal year 2015: -$31.70 million | Fiscal year 2014: -$66.16 million | Fiscal year 2013: -$79.29 million | Fiscal year 2012: -$94.47 million | Fiscal year 2011: -$109.39 million | Fiscal year 2010: -$140.17 million | Fiscal year 2009: -$87.70 million.
- Data sourced from SEC EDGAR public filings as of August 8, 2026.
Last verified: